{
 "PrintNo":"S4482","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-03-13T09:14:45.180295Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-03-13","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":1233,"Name":"Pete Harckham","Short":"HARCKHAM"},{"ID":1226,"Name":"Jessica Ramos","Short":"RAMOS"},
  {"ID":1227,"Name":"Julia Salazar","Short":"SALAZAR"}
 ],
 "Title":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry",
 "Summary":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3343-a, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry",
 "SameAsPrintNo":"A3741-2019","PreviousVersions":["S4374-2017"]
}